FR20C1050I2 - Cephalosporine comprenant un groupe catechol - Google Patents

Cephalosporine comprenant un groupe catechol

Info

Publication number
FR20C1050I2
FR20C1050I2 FR20C1050C FR20C1050C FR20C1050I2 FR 20C1050 I2 FR20C1050 I2 FR 20C1050I2 FR 20C1050 C FR20C1050 C FR 20C1050C FR 20C1050 C FR20C1050 C FR 20C1050C FR 20C1050 I2 FR20C1050 I2 FR 20C1050I2
Authority
FR
France
Prior art keywords
cephalosporin
catechol group
catechol
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR20C1050C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42128829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1050(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR20C1050I1 publication Critical patent/FR20C1050I1/fr
Application granted granted Critical
Publication of FR20C1050I2 publication Critical patent/FR20C1050I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/10—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D505/12—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7
    • C07D505/14—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7 with hetero atoms directly attached in position 7
    • C07D505/16—Nitrogen atoms
    • C07D505/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D505/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D505/24—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by doubly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR20C1050C 2008-10-31 2020-10-15 Cephalosporine comprenant un groupe catechol Active FR20C1050I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008280828 2008-10-31
EP09823578.1A EP2341053B1 (fr) 2008-10-31 2009-10-27 Céphalosporine possédant un groupe catéchol

Publications (2)

Publication Number Publication Date
FR20C1050I1 FR20C1050I1 (fr) 2020-11-27
FR20C1050I2 true FR20C1050I2 (fr) 2021-10-15

Family

ID=42128829

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20C1050C Active FR20C1050I2 (fr) 2008-10-31 2020-10-15 Cephalosporine comprenant un groupe catechol

Country Status (38)

Country Link
US (1) US9238657B2 (fr)
EP (2) EP2960244B1 (fr)
JP (2) JP5498393B2 (fr)
KR (1) KR101655961B1 (fr)
CN (1) CN102203100B (fr)
AU (1) AU2009310959B2 (fr)
BR (1) BRPI0921701B8 (fr)
CA (1) CA2736953C (fr)
CL (1) CL2011000939A1 (fr)
CO (1) CO6331443A2 (fr)
CR (1) CR20110144A (fr)
CY (2) CY1118536T1 (fr)
DK (1) DK2960244T3 (fr)
EA (1) EA019520B1 (fr)
ES (2) ES2602969T3 (fr)
FI (1) FIC20200039I1 (fr)
FR (1) FR20C1050I2 (fr)
HR (1) HRP20161408T1 (fr)
HU (2) HUE031802T2 (fr)
IL (1) IL211720A (fr)
LT (2) LT2960244T (fr)
MA (1) MA32731B1 (fr)
ME (1) ME02666B (fr)
MX (1) MX2011004636A (fr)
MY (1) MY155655A (fr)
NL (1) NL301067I2 (fr)
NO (1) NO2020035I1 (fr)
NZ (1) NZ591728A (fr)
PE (1) PE20120010A1 (fr)
PL (1) PL2960244T3 (fr)
PT (1) PT2960244T (fr)
RS (1) RS55365B1 (fr)
SI (1) SI2960244T1 (fr)
SM (1) SMT201600397B (fr)
TW (1) TWI535727B (fr)
UA (1) UA105190C2 (fr)
WO (1) WO2010050468A1 (fr)
ZA (1) ZA201102024B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5733856B2 (ja) 2007-10-09 2015-06-10 ソファーミア，インコーポレイテッド 広帯域β−ラクタマーゼ阻害薬
ES2602969T3 (es) * 2008-10-31 2017-02-23 Shionogi & Co., Ltd. Cefalosporinas que tienen un grupo catecol
EP2557082A4 (fr) 2010-04-05 2013-08-28 Shionogi & Co Composé de céphème comprenant un groupe catéchol
US8883773B2 (en) 2010-04-05 2014-11-11 Shionogi & Co., Ltd. Cephem compound having pseudo-catechol group
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative
CN103502218B (zh) 2011-03-04 2016-08-17 生命科技公司 用于缀合生物分子的化合物和方法
KR101719556B1 (ko) * 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
JP6006201B2 (ja) * 2011-04-28 2016-10-12 塩野義製薬株式会社 カテコールまたは擬似カテコール構造を有する新規セフェム化合物
CN103619853A (zh) 2011-06-27 2014-03-05 盐野义制药株式会社 具有吡啶鎓基的头孢烯化合物
TWI547496B (zh) * 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
WO2013051597A1 (fr) 2011-10-04 2013-04-11 塩野義製薬株式会社 Dérivé céphem ayant un groupe catéchol
RU2015120084A (ru) 2012-10-29 2016-12-27 Сионоги Энд Ко., Лтд. Способы получения промежуточных соединений для 2-алкилцефемовых соединений
UY35103A (es) * 2012-10-29 2014-05-30 Glaxo Group Ltd Compuestos de cefem 2-sustituidos
JPWO2014104148A1 (ja) * 2012-12-26 2017-01-12 塩野義製薬株式会社 セフェム化合物
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
SI3122745T1 (sl) 2014-03-24 2019-05-31 Novartis Ag Organske spojine monobaktama za zdravljenje bakterijskih infekcij
JP6377570B2 (ja) * 2014-04-28 2018-08-22 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ ２−置換セフェム化合物を含有する医薬組成物
EP3882252A1 (fr) 2014-06-11 2021-09-22 Venatorx Pharmaceuticals, Inc. Inhibiteurs de bêta-lactamase
CN106687116B (zh) * 2014-09-04 2020-07-24 盐野义制药株式会社 含有具有儿茶酚基的头孢菌素类的制剂
RS62449B1 (sr) * 2014-09-04 2021-11-30 Shionogi & Co So derivata cefalosporina, njen kristalni čvrst oblik i postupak njene proizvodnje
CN106661052B (zh) * 2014-09-04 2021-05-11 盐野义制药株式会社 头孢菌素衍生物的中间体及其制造方法
US10464896B2 (en) 2015-06-11 2019-11-05 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
SI3353175T1 (sl) 2015-09-23 2020-11-30 Novartis Ag Soli in trdne oblike monobaktam antibiotika
EP3386977A4 (fr) * 2015-12-10 2019-05-22 NAEJA-RGM Pharmaceuticals ULC Composés de céphème, leur préparation et utilisation
CN108699059B (zh) 2016-03-08 2021-06-18 诺华股份有限公司 可用于治疗正粘病毒感染的三环化合物
US20200316083A1 (en) * 2016-06-17 2020-10-08 Wockhardt Limited Antibacterial compositions
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
US10933051B2 (en) * 2017-06-09 2021-03-02 Fob Synthesis, Inc. Carbapenem compounds and compositions for the treatment of bacterial infections
CA3063649A1 (fr) 2017-08-02 2019-02-07 Novartis Ag Processus chimique de preparation d'antibiotique monobactame et de ses intermediaires
US11629149B2 (en) 2018-02-28 2023-04-18 Novartis Ag 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
WO2020184399A1 (fr) * 2019-03-08 2020-09-17 塩野義製薬株式会社 Composition pharmaceutique antibactérienne
TW202126664A (zh) 2019-09-06 2021-07-16 奧地利商納畢瓦治療有限責任公司 鐵載體頭孢菌素共軛物及其用途
AU2021210472A1 (en) * 2020-01-22 2022-07-21 Jiangsu Hengrui Medicine Co., Ltd. Cephalosporin antibacterial compound and pharmaceutical application thereof
TW202220663A (zh) 2020-07-28 2022-06-01 日商鹽野義製藥股份有限公司 含有具有鄰苯二酚基之頭孢菌素類的凍結乾燥製劑及其製造方法
KR20230131292A (ko) * 2021-01-12 2023-09-12 상하이 센후이 메디슨 컴퍼니 리미티드 세팔로스포린 항균 화합물 및 이의 제조 방법
CN113698365A (zh) * 2021-08-30 2021-11-26 成都大学 一种头孢地尔侧链的制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47168A (en) 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS57118588A (en) 1981-11-26 1982-07-23 Toyama Chem Co Ltd Novel cephalosporin
DE3207840A1 (de) 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
DE3470314D1 (en) 1983-01-21 1988-05-11 Beecham Group Plc Beta-lactam antibacterial agents
NO165842C (no) 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
EP0168177A3 (fr) 1984-06-28 1987-04-01 Pfizer Limited Céphalosporines antibiotiques
DE3688477T2 (de) 1985-03-01 1993-09-16 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
JPH068300B2 (ja) * 1985-08-02 1994-02-02 萬有製薬株式会社 新規セフアロスポリン誘導体
EP0211656A3 (fr) 1985-08-10 1988-03-09 Beecham Group Plc Dérivés de céphalosporine, procédé pour leur préparation et les compositions pharmaceutiques les contenant
EP0214600B1 (fr) * 1985-09-03 1992-12-02 Otsuka Kagaku Kabushiki Kaisha Dérivés de céphalosporine
JPH07107069B2 (ja) * 1985-09-03 1995-11-15 大塚化学株式会社 セフアロスポリン化合物の新規誘導体、その製造法及び該誘導体を含有する医薬組成物
JPS62158291A (ja) * 1986-01-07 1987-07-14 Sagami Chem Res Center セフアロスポリン誘導体
EP0241901B1 (fr) * 1986-04-14 1994-08-24 Banyu Pharmaceutical Co., Ltd. Dérivés de céphalosporine, leurs procédés de préparation et agents antibactériens
DE3787030T2 (de) * 1986-04-14 1994-04-07 Banyu Pharma Co Ltd 1-carboxy-1-vinyloxyiminoaminothiazol-cephalosporin-derivate und deren herstellung.
IE61679B1 (en) 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
GB8719875D0 (en) 1987-08-22 1987-09-30 Beecham Group Plc Compounds
JPH0228185A (ja) 1988-04-14 1990-01-30 Tanabe Seiyaku Co Ltd セファロスポリン化合物及びその合成中間体
GB8811055D0 (en) 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
US5149803A (en) * 1988-05-10 1992-09-22 Imperial Chemical Industries Plc Intermediates for cephalosporin compounds
US5244890A (en) 1988-06-06 1993-09-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
PH25965A (en) * 1988-06-06 1992-01-13 Fujisawa Pharmaceutical Co New cephem compounds which have antimicrobial activities
GB8813945D0 (en) 1988-06-13 1988-07-20 Fujisawa Pharmaceutical Co New cephem compounds & process for preparation thereof
GB8817653D0 (en) * 1988-07-25 1988-09-01 Fujisawa Pharmaceutical Co New cephem compounds & processes for preparation thereof
CA2005787A1 (fr) 1988-12-29 1990-06-29 Masao Wada Composes de cephalosporine
JPH02275886A (ja) 1988-12-29 1990-11-09 Tanabe Seiyaku Co Ltd セファロスポリン化合物及びその製法
US5143910A (en) 1989-09-07 1992-09-01 Shionogi & Co., Ltd. Piperaziniocephalosporins
GB9005246D0 (en) 1990-03-08 1990-05-02 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US5095012A (en) 1990-08-23 1992-03-10 Bristol-Myers Squibb Company Antibiotic c-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
US5234920A (en) 1990-08-23 1993-08-10 Bristol-Myers Squibb Company Antibiotic C-7 catechol-substituted cephalosporin compounds, compositions, and method of use thereof
US5126336A (en) 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
US5194433A (en) 1990-11-13 1993-03-16 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
GB9111406D0 (en) 1991-05-28 1991-07-17 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
GB9118672D0 (en) 1991-08-30 1991-10-16 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
EP0628562A1 (fr) 1993-06-10 1994-12-14 Roussel Uclaf Céphalosporines comportant en position 7 un radical oxymino substitué, leurs intermédiaires, leurs procédé de préparation et leur application comme médicaments
AU1694099A (en) 1997-12-26 1999-07-19 Cheil Jedang Corporation Cephem derivatives and a method for producing the compounds and an antibacterialcomposition containing the compounds
WO2002076979A1 (fr) 2001-03-27 2002-10-03 Actelion Pharmaceuticals Ltd Derives de 1,2,3,4-tetrahydro-isoquinoline en tant qu'antagonistes du recepteur de l'urotensine ii
JP2003078440A (ja) 2001-08-30 2003-03-14 Kyocera Corp 高周波スイッチ回路
TW200305422A (en) 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
WO2003099826A1 (fr) 2002-05-23 2003-12-04 Orchid Chemicals And Pharmaceuticals Limited Nouvelle methode de preparation de cefditorene utilisant le thioester d'acide thiazolylacetique
JP4892926B2 (ja) 2005-10-25 2012-03-07 宇部興産株式会社 スルホン化芳香族ブロック共重合体の製造方法
TW200637559A (en) 2005-03-29 2006-11-01 Shionogi & Co 3-propenylcefem derivative
JP4557859B2 (ja) 2005-09-29 2010-10-06 富士通株式会社 周波数分割多重送受信装置及び送受信方法
WO2007096740A2 (fr) 2006-02-20 2007-08-30 Orchid Research Laboratories Limited Nouvelles céphalosporines
WO2007119511A1 (fr) * 2006-03-16 2007-10-25 Astellas Pharma Inc. Composés de céphem et leur utilisation en tant qu'agents antimicrobiens
ES2602969T3 (es) 2008-10-31 2017-02-23 Shionogi & Co., Ltd. Cefalosporinas que tienen un grupo catecol
US8883773B2 (en) 2010-04-05 2014-11-11 Shionogi & Co., Ltd. Cephem compound having pseudo-catechol group
EP2557082A4 (fr) 2010-04-05 2013-08-28 Shionogi & Co Composé de céphème comprenant un groupe catéchol
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative

Also Published As

Publication number Publication date
JPWO2010050468A1 (ja) 2012-03-29
ES2602969T3 (es) 2017-02-23
EA019520B1 (ru) 2014-04-30
CN102203100B (zh) 2014-08-27
CL2011000939A1 (es) 2011-09-16
DK2960244T3 (en) 2016-11-28
MY155655A (en) 2015-11-13
CO6331443A2 (es) 2011-10-20
SMT201600397B (it) 2017-01-10
RS55365B1 (sr) 2017-03-31
FIC20200039I1 (fi) 2020-10-19
EP2341053A1 (fr) 2011-07-06
CY2020034I2 (el) 2021-05-05
AU2009310959A1 (en) 2010-05-06
KR101655961B1 (ko) 2016-09-08
NZ591728A (en) 2012-12-21
CY1118536T1 (el) 2017-07-12
ZA201102024B (en) 2014-08-27
NO2020035I1 (no) 2020-10-21
NL301067I1 (fr) 2020-10-13
US20110190254A1 (en) 2011-08-04
IL211720A (en) 2015-01-29
LT2960244T (lt) 2016-11-25
HRP20161408T1 (hr) 2016-12-02
CR20110144A (es) 2011-09-09
AU2009310959B2 (en) 2015-05-07
MX2011004636A (es) 2011-06-20
EP2960244A1 (fr) 2015-12-30
PT2960244T (pt) 2016-11-02
FR20C1050I1 (fr) 2020-11-27
UA105190C2 (ru) 2014-04-25
BRPI0921701A2 (pt) 2020-08-11
CY2020034I1 (el) 2020-11-25
EP2341053B1 (fr) 2016-01-13
KR20110090982A (ko) 2011-08-10
NL301067I2 (nl) 2020-10-28
MA32731B1 (fr) 2011-10-02
HUS2000042I1 (hu) 2020-11-30
BRPI0921701B8 (pt) 2022-06-07
LTPA2020530I1 (lt) 2020-11-10
US9238657B2 (en) 2016-01-19
EA201170632A1 (ru) 2011-12-30
JP2014065732A (ja) 2014-04-17
IL211720A0 (en) 2011-06-30
EP2341053A4 (fr) 2012-08-08
JP5498393B2 (ja) 2014-05-21
HUE031802T2 (en) 2017-08-28
ME02666B (fr) 2017-06-20
CN102203100A (zh) 2011-09-28
PE20120010A1 (es) 2012-02-07
SI2960244T1 (sl) 2017-02-28
PL2960244T3 (pl) 2017-03-31
TWI535727B (zh) 2016-06-01
TW201020259A (en) 2010-06-01
CA2736953A1 (fr) 2010-05-06
WO2010050468A1 (fr) 2010-05-06
ES2564836T3 (es) 2016-03-29
CA2736953C (fr) 2017-07-11
BRPI0921701B1 (pt) 2022-05-03
EP2960244B1 (fr) 2016-09-14

Similar Documents

Publication Publication Date Title
FR20C1050I2 (fr) Cephalosporine comprenant un groupe catechol
BRPI1012352A2 (pt) plataforma de aplicação hospedada com formato de mídia extensível
DK2466312T3 (da) Phosphoethanolamine som biomarkør for depression
BRPI0912260A2 (pt) tonalizador.
IT1393131B1 (it) Controvento a ingobbamento limitato
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
NO20075187L (no) Et marint sokesystem
AU321707S (en) Data projector
HK1161423A1 (en) Inverted organic photosensitive devices
EP2350740A4 (fr) Système de projection
AU333600S (en) Photosensitive drum unit
AU324436S (en) Data projector
EP2632732A4 (fr) Support photo
IT1404483B1 (it) Un collegamento ad innesto per occhiali.
TWI366736B (en) Projector
GB2448414B (en) Photographic child support
FR2962626B1 (fr) Bineuse autoguidee composee d'un chassis
TWI372303B (en) Projector
TWI366734B (en) Projector
ES1068546Y (es) Cama
UA21752S (uk) Фігура - оберіг
UA18484S (uk) Подушка для дітей
CN301301256S (zh) 投影仪
IT1400189B1 (it) Letto a doghe
TWM388664U (en) Exposure machine having humidity regulatory function